Paneth Cell Secreted Effectors in Mucosal Innate Immunity
Paneth Cell Secreted Effectors in Mucosal Innate Immunity
批准号:
9295954
负责人:
Charles L Bevins
金额:
$46.16万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-06-15 至 2021-05-31
关键词:
AgglutinationAllelesAnimalsAutophagocytosisBacteriaBacterial InfectionsBindingBiochemicalBiological AssayBiological ProcessBiological TestingBiologyC57BL/6 MouseCarbohydratesCell physiologyCell secretionCharacteristicsChemicalsChronicCodeColitisCommunicable DiseasesComplement ActivationComplementary DNACrohn&aposs diseaseDataDiseaseEnteralEpithelial CellsEquilibriumFoundationsFrequenciesFunctional disorderGeneral PopulationGenetic RiskGlycolsGoalsHomeostasisHost DefenseHumanIleitisImmune responseImmune systemImmunityImmunologicsImpairmentIn VitroIndividualInflammatoryInflammatory Bowel DiseasesInnate Immune SystemIntestinesInvertebratesInvestigationKnock-outKnowledgeLaboratoriesLeadLectinMaintenanceMammalsMediatingMediator of activation proteinMicrobeModelingMolecularMucosal ImmunityMucous MembraneMuramidaseMusNamesNatural ImmunityNatureOrthologous GenePaneth CellsPathogenesisPathogenicityPathologyPathway interactionsPatternPeptidesPhagocytosisPredispositionPropertyProtein IsoformsProteinsPublishingRecombinantsReportingRisk FactorsRoleSecretory VesiclesSmall IntestinesSpecimenSurfaceTestingUrochordataVariantWorkalpha-Defensinsantimicrobialascidianbasedisorder controlendoplasmic reticulum stressenteric pathogenexperimental studygenetic varianthost-microbe interactionsin vitro activityin vivoinnovationinsightmicrobialmicrobiotamisfolded proteinnovel therapeutic interventionpathogenrare variantreceptorresponserisk variantsecretory protein
中文摘要
粘膜组织的免疫系统必须有效地保护宿主免受病原体的侵袭
英文摘要
The immune system of mucosal tissues must effectively protect the host from pathogen invasion, while
facilitating homeostatic interactions with a diverse colonizing microbiota. A clear understanding of the key
molecules and mechanisms that achieve this delicate balance remains incomplete, leaving a gap in critical
knowledge. Paneth cells of the small intestine secrete large quantities of proteins and peptides into the lumen
that mediate both interrelated functions of host defense and maintenance of homeostasis. Compelling
published evidence from many laboratories, including ours, suggests that defective Paneth cell function
increases susceptibility to chronic inflammatory bowel disease (IBD) and to enteric pathogens. This
investigation will focus on a secreted protein that our preliminary data suggests is among the most abundant
secretory proteins of human Paneth cells, an understudied intestinal lectin named intelectin. Intelectin
orthologs widely span the animal Kingdom, from mammals to the invertebrate sea squirts. Recent published
data demonstrate that intelectin has molecular pattern binding activity characteristic of the innate immune
system, in that it binds to carbohydrates found on a variety microbes - through interaction with exocyclic 1, 2
diols - but does not bind to host carbohydrates because of steric hindrance. Our preliminary data identify
qualitative and quantitative aberrations of the two isoforms of intelectin (ITLN1 and ITLN2) in small intestinal
specimens from individuals with ileal Crohn's disease (CD) compared to controls. While statistically significant,
the mechanisms that may tie these changes to impaired innate immunity in CD are unknown and will be
investigated. Our hypothesis, based on published and preliminary data, is that intelectin is a critical mediator
of host-microbe interaction in the intestine. Aim 1 will determine the relative expression levels of ITLN1 and
ITLN2 in small intestinal CD and control specimens, and biochemically characterize intelectin isolated from
human small intestine. Aim 2 will investigate the in vitro activity of intelectin isoforms in vitro. Aim 3 will
establish innate immunological consequences of intelectin expression using newly generated C57BL/6 Itln-/-
mice. Our goal is to elucidate a fundamental understanding on the role of intelectin in mucosal protection, and
in so doing, fill a void in our understanding of a conserved, highly abundant secretory protein of human Paneth
cells. Successful completion of these studies will likely have broad impact on our mechanistic understanding
of innate immunity in the small intestine.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
2015 Antimicrobial Peptides Gordon Research Conference & Gordon Research Seminar
-
批准号:8895489
-
项目类别:
-
资助金额:$0.5万
-
财政年份:2015
-
负责人:Charles L Bevins
-
依托单位:
New Mouse Models of Paneth Cell Defensin Function
-
批准号:8422985
-
项目类别:
-
资助金额:$19.21万
-
财政年份:2012
-
负责人:Charles L Bevins
-
依托单位:
New Mouse Models of Paneth Cell Defensin Function
-
批准号:8286104
-
项目类别:
-
资助金额:$23.07万
-
财政年份:2012
-
负责人:Charles L Bevins
-
依托单位:
Defensin gene copy number and mucosal innate immunity
-
批准号:7819960
-
项目类别:
-
资助金额:$50.0万
-
财政年份:2010
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6620934
-
项目类别:
-
资助金额:$3.05万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6883922
-
项目类别:
-
资助金额:$30.99万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6854401
-
项目类别:
-
资助金额:$27.58万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:7026937
-
项目类别:
-
资助金额:$30.26万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6423661
-
项目类别:
-
资助金额:$32.1万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
In vivo Models of Defensin Activity
-
批准号:6693823
-
项目类别:
-
资助金额:$31.14万
-
财政年份:2002
-
负责人:Charles L Bevins
-
依托单位:
2001 Antimicrobial Peptides Gordon Conference
-
批准号:6368399
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2001
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:6510700
-
项目类别:
-
资助金额:$25.95万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2067628
-
项目类别:
-
资助金额:$23.53万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2688491
-
项目类别:
-
资助金额:$23.05万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7477101
-
项目类别:
-
资助金额:$31.47万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7088896
-
项目类别:
-
资助金额:$32.93万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2067627
-
项目类别:
-
资助金额:$20.25万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:2886752
-
项目类别:
-
资助金额:$23.75万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
NOVEL DEFENSINS IN HUMAN EPITHELIAL TISSUE
-
批准号:3147858
-
项目类别:
-
资助金额:$19.11万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
Novel Defensins of Human Epithelia
-
批准号:7216832
-
项目类别:
-
资助金额:$32.08万
-
财政年份:1993
-
负责人:Charles L Bevins
-
依托单位:
海外基金